| 2017-03-10 | Sale | Viridian Therapeutics, Inc. VRDN | director | 3,300 0.0293% | $14.31 | $47,229 | -33.81% | |
| 2017-03-09 | Sale | Viridian Therapeutics, Inc. VRDN | director | 2,500 0.0219% | $14.38 | $35,962 | -34.81% | |
| 2017-03-08 | Sale | Viridian Therapeutics, Inc. VRDN | director | 5,000 0.0454% | $14.70 | $73,514 | -33.86% | |
| 2017-03-06 | Sale | Viridian Therapeutics, Inc. VRDN | director | 10,000 0.0879% | $15.75 | $157,463 | -40.06% | |
| 2017-02-28 | Sale | Viridian Therapeutics, Inc. VRDN | director | 2,258 0.0202% | $13.54 | $30,580 | -28.49% | |
| 2017-02-27 | Sale | Viridian Therapeutics, Inc. VRDN | director | 1,500 0.0128% | $13.79 | $20,687 | -32.65% | |
| 2017-02-24 | Sale | Viridian Therapeutics, Inc. VRDN | director | 6,500 0.0564% | $14.04 | $91,252 | -32.67% | |
| 2017-02-23 | Sale | Viridian Therapeutics, Inc. VRDN | director | 1,800 0.0152% | $13.65 | $24,566 | -32.67% | |
| 2017-02-22 | Sale | Viridian Therapeutics, Inc. VRDN | director | 4,102 0.0363% | $14.36 | $58,886 | -32.88% |